PE20120031A1 - Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1 - Google Patents
Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1Info
- Publication number
- PE20120031A1 PE20120031A1 PE2011001058A PE2011001058A PE20120031A1 PE 20120031 A1 PE20120031 A1 PE 20120031A1 PE 2011001058 A PE2011001058 A PE 2011001058A PE 2011001058 A PE2011001058 A PE 2011001058A PE 20120031 A1 PE20120031 A1 PE 20120031A1
- Authority
- PE
- Peru
- Prior art keywords
- receptor
- positive allosteric
- allosteric modulators
- compounds
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/19—Acids containing three or more carbon atoms
- C07C53/21—Acids containing three or more carbon atoms containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Abstract
REFERIDA A UN COMPUESTO DE FORMULA I, DONDE X, E, Z Y Q SON CADA UNO C, CH O UNO DE X, E, Z Y Q ES N Y LOS OTROS CH, C O JUNTOS INCLUYENDO R1 ESTAN ENLAZADOS PARA FORMAR NAFTILO; R1 ES H, ARILO, HETEROARILO, HALOGENO, CN, ENTRE OTROS; R2 ES H, ARILO, O-(ALQUILO C1-C6), CICLOALQUILO C3-C8, ENTRE OTROS; R3 ES H, ALQUILO C1-C6, HALOGENO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 6-(4-METOXIBENCIL)-3-(5-METIL)-1H-PIRAZOL-3-ILBENZO[H]QUINAZOLIN-4(3H)-ONA; RAC-3-[TRANS-2-HIDROXICICLOHEXIL]-6-{[6-(1-METIL-1H-PIRAZOL-4-IL)PIRIDINA-3-IL]METIL}BENZO[H] QUINAZOLIN-4(3H)-ONA; ENTRE OTROS. REFERIDA ADEMAS A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES ALOSTERICOS POSITIVOS DEL RECEPTOR M1 MUSCARINICO, UTILES EN EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER Y OTRAS ENFERMEDADES MEDIADAS POR EL RECEPTOR M1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19974008P | 2008-11-20 | 2008-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20120031A1 true PE20120031A1 (es) | 2012-02-05 |
Family
ID=41565956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011001058A PE20120031A1 (es) | 2008-11-20 | 2009-11-19 | Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1 |
Country Status (37)
Country | Link |
---|---|
US (4) | US8557832B2 (es) |
EP (1) | EP2358686B1 (es) |
JP (1) | JP5102397B2 (es) |
KR (1) | KR101305590B1 (es) |
CN (1) | CN102292323B (es) |
BR (1) | BRPI0921924A2 (es) |
CA (1) | CA2743562C (es) |
CO (1) | CO6361928A2 (es) |
CR (1) | CR20110268A (es) |
CY (1) | CY1113665T1 (es) |
DK (1) | DK2358686T3 (es) |
DO (1) | DOP2011000135A (es) |
EA (1) | EA019098B1 (es) |
EC (1) | ECSP11011066A (es) |
ES (1) | ES2393694T3 (es) |
GE (1) | GEP20156348B (es) |
GT (1) | GT201100127A (es) |
HK (1) | HK1154587A1 (es) |
HN (1) | HN2011001358A (es) |
HR (1) | HRP20120992T1 (es) |
IL (1) | IL212573A (es) |
MA (1) | MA32898B1 (es) |
MX (1) | MX2011005284A (es) |
MY (1) | MY162502A (es) |
NI (1) | NI201100100A (es) |
NZ (1) | NZ592961A (es) |
PE (1) | PE20120031A1 (es) |
PL (1) | PL2358686T3 (es) |
PT (1) | PT2358686E (es) |
RS (1) | RS52528B (es) |
SG (1) | SG171769A1 (es) |
SI (1) | SI2358686T1 (es) |
SV (1) | SV2011003912A (es) |
TN (1) | TN2011000209A1 (es) |
UA (1) | UA100459C2 (es) |
WO (1) | WO2010059773A1 (es) |
ZA (1) | ZA201103612B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102480964B (zh) * | 2009-08-31 | 2015-07-08 | 默沙东公司 | 吡喃基芳基甲基苯并喹唑啉酮m1受体正向别构调节剂 |
EP2490692B1 (en) | 2009-10-21 | 2016-11-16 | Merck Sharp & Dohme Corp. | Quinolinone-pyrazolone m1 receptor positive allosteric modulators |
EP2512245B1 (en) * | 2009-12-14 | 2014-07-23 | Merck Sharp & Dohme Corp. | Pyridoquinazolinone m1 receptor positive allosteric modulators |
EP2512243B1 (en) | 2009-12-17 | 2016-04-06 | Merck Sharp & Dohme Corp. | Quinoline amide m1 receptor positive allosteric modulators |
WO2011084371A1 (en) * | 2009-12-21 | 2011-07-14 | Merck Sharp & Dohme Corp. | Aminobenzoquinazolinone m1 receptor positive allosteric modulators |
EP2582241B1 (en) | 2010-06-15 | 2016-04-06 | Merck Sharp & Dohme Corp. | Heterocyclic fused phenanthrolinone m1 receptor positive allosteric modulators |
WO2012003147A1 (en) | 2010-07-01 | 2012-01-05 | Merck Sharp & Dohme Corp. | Isoindolone m1 receptor positive allosteric modulators |
WO2012047702A1 (en) * | 2010-10-04 | 2012-04-12 | Merck Sharp & Dohme Corp. | Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators |
EP2709624B1 (en) * | 2011-05-17 | 2016-04-27 | Merck Sharp & Dohme Corp. | N-methyl tetrahydroquinoline m1 receptor positive allosteric modulators |
MX2014001604A (es) | 2011-08-12 | 2014-04-14 | Basf Se | Compuestos de antranilamida y sus usos como plaguicidas. |
CA2843084A1 (en) | 2011-08-12 | 2013-02-21 | Basf Se | Anthranilamide compounds and their use as pesticides |
WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
US9233911B2 (en) | 2012-01-10 | 2016-01-12 | Council Of Scientific & Industrial Research | Cu-mediated annulation for the production of 1-amino-2-naphthalenecarboxylic acid derivatives |
EP2821401B1 (en) | 2012-03-02 | 2020-09-09 | Takeda Pharmaceutical Company Limited | Dihydroquinolinone compounds as modulators of the muscarininc m1 receptor |
JP6211530B2 (ja) | 2012-11-19 | 2017-10-11 | 武田薬品工業株式会社 | 含窒素複素環化合物 |
GB201317363D0 (en) | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
CN106232572B (zh) * | 2014-04-17 | 2018-11-13 | 住友化学株式会社 | 硝基化合物的制造方法 |
CA2978214A1 (en) * | 2015-03-06 | 2016-09-15 | Chase Pharmaceuticals Corporation | Peripheral-anticholinergic muscarinic agonist combination |
CN107922403A (zh) * | 2015-06-26 | 2018-04-17 | 武田药品工业株式会社 | 作为胆碱能毒蕈碱m1受体的调节剂的2,3‑二氢‑4h‑1,3‑苯并噁嗪‑4‑酮衍生物 |
EP3347011A4 (en) | 2015-09-11 | 2019-06-19 | Chase Pharmaceuticals Corporation | MUSCARIN COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGEN DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
EP3356333A4 (en) * | 2015-09-30 | 2019-03-27 | Merck Sharp & Dohme Corp. | CRYSTAL FORMS OF AN M1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR |
WO2017058691A1 (en) * | 2015-09-30 | 2017-04-06 | Merck Sharp & Dohme Corp. | Process for making m1 receptor positive allosteric modulators |
JP6787913B2 (ja) * | 2015-10-20 | 2020-11-18 | 武田薬品工業株式会社 | 複素環化合物 |
EP3442972B1 (en) | 2016-04-15 | 2020-03-04 | AbbVie Inc. | Bromodomain inhibitors |
TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
CN109843056A (zh) | 2016-10-14 | 2019-06-04 | 印度商皮埃企业有限公司 | 4-经取代之苯基胺衍生物及其通过对抗不要的植物病原性微生物而保护作物之用途 |
EP3535253A1 (en) | 2016-11-01 | 2019-09-11 | H. Hoffnabb-La Roche Ag | 1,3-dihydro-1,4-benzodiazepine-2-thiones for the treatment of cns related diseases |
US20200182850A1 (en) | 2017-05-19 | 2020-06-11 | Takeda Pharmaceutical Company Limited | Screening method |
US20210347786A1 (en) | 2018-09-28 | 2021-11-11 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
US20240092783A1 (en) | 2021-03-18 | 2024-03-21 | Merck Patent Gmbh | Heteroaromatic compounds for organic electroluminescent devices |
WO2023114224A1 (en) | 2021-12-13 | 2023-06-22 | Sage Therapeutics, Inc. | Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0856001B1 (en) * | 1995-10-02 | 2002-08-28 | F. Hoffmann-La Roche Ag | Pyrimidine derivatives as 5ht2c receptor antagonists |
EP0946523A1 (en) * | 1996-12-23 | 1999-10-06 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
KR100607634B1 (ko) | 1998-10-16 | 2006-08-02 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 퀴나졸리논 유도체 |
JP2005089298A (ja) * | 2001-09-18 | 2005-04-07 | Japan Tobacco Inc | ナフタレン化合物及びその医薬用途 |
WO2004073639A2 (en) | 2003-02-19 | 2004-09-02 | Merck & Co. Inc. | Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
BRPI0611537A2 (pt) * | 2005-05-04 | 2010-09-21 | Hoffmann La Roche | (3,4-diidro-quinazolin-2-il) -(2-arilóxi-etil)-aminas tendo uma atividade sobre o receptor de 5-ht |
EP2037739B1 (en) * | 2006-06-28 | 2011-10-26 | Merck Sharp & Dohme Corp. | Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
WO2012047702A1 (en) * | 2010-10-04 | 2012-04-12 | Merck Sharp & Dohme Corp. | Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators |
-
2009
- 2009-11-19 US US13/129,593 patent/US8557832B2/en active Active
- 2009-11-19 DK DK09761104.0T patent/DK2358686T3/da active
- 2009-11-19 MX MX2011005284A patent/MX2011005284A/es active IP Right Grant
- 2009-11-19 SG SG2011036472A patent/SG171769A1/en unknown
- 2009-11-19 EP EP09761104A patent/EP2358686B1/en active Active
- 2009-11-19 GE GEAP200912265A patent/GEP20156348B/en unknown
- 2009-11-19 MY MYPI2011002215A patent/MY162502A/en unknown
- 2009-11-19 EA EA201170705A patent/EA019098B1/ru not_active IP Right Cessation
- 2009-11-19 KR KR1020117011415A patent/KR101305590B1/ko active IP Right Grant
- 2009-11-19 PL PL09761104T patent/PL2358686T3/pl unknown
- 2009-11-19 BR BRPI0921924A patent/BRPI0921924A2/pt active Search and Examination
- 2009-11-19 ES ES09761104T patent/ES2393694T3/es active Active
- 2009-11-19 PE PE2011001058A patent/PE20120031A1/es not_active Application Discontinuation
- 2009-11-19 SI SI200930460T patent/SI2358686T1/sl unknown
- 2009-11-19 CA CA2743562A patent/CA2743562C/en active Active
- 2009-11-19 NZ NZ592961A patent/NZ592961A/xx not_active IP Right Cessation
- 2009-11-19 RS RS20120522A patent/RS52528B/en unknown
- 2009-11-19 CN CN200980155011.4A patent/CN102292323B/zh active Active
- 2009-11-19 PT PT97611040T patent/PT2358686E/pt unknown
- 2009-11-19 JP JP2011537601A patent/JP5102397B2/ja active Active
- 2009-11-19 WO PCT/US2009/065060 patent/WO2010059773A1/en active Application Filing
- 2009-11-19 UA UAA201107595A patent/UA100459C2/ru unknown
-
2011
- 2011-04-28 IL IL212573A patent/IL212573A/en not_active IP Right Cessation
- 2011-04-29 TN TN2011000209A patent/TN2011000209A1/fr unknown
- 2011-05-12 DO DO2011000135A patent/DOP2011000135A/es unknown
- 2011-05-17 GT GT201100127A patent/GT201100127A/es unknown
- 2011-05-17 ZA ZA2011/03612A patent/ZA201103612B/en unknown
- 2011-05-17 NI NI201100100A patent/NI201100100A/es unknown
- 2011-05-19 HN HN2011001358A patent/HN2011001358A/es unknown
- 2011-05-20 CR CR20110268A patent/CR20110268A/es unknown
- 2011-05-20 SV SV2011003912A patent/SV2011003912A/es unknown
- 2011-05-20 EC EC2011011066A patent/ECSP11011066A/es unknown
- 2011-05-24 CO CO11063884A patent/CO6361928A2/es active IP Right Grant
- 2011-06-13 MA MA33939A patent/MA32898B1/fr unknown
- 2011-08-25 HK HK11108976.8A patent/HK1154587A1/xx not_active IP Right Cessation
-
2012
- 2012-12-03 HR HRP20120992AT patent/HRP20120992T1/hr unknown
- 2012-12-17 CY CY20121101227T patent/CY1113665T1/el unknown
-
2013
- 2013-08-29 US US14/013,184 patent/US8883810B2/en active Active
-
2014
- 2014-10-08 US US14/509,580 patent/US20150031713A1/en not_active Abandoned
-
2015
- 2015-08-17 US US14/828,216 patent/US9708273B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20120031A1 (es) | Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1 | |
PE20180500A1 (es) | Derivados de 2,3-dihidro-4h-1,3-benzoxazin-4-ona como moduladores del receptor muscarinico colinergico m1 | |
AR077935A1 (es) | Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina | |
PE20110028A1 (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
PE20100718A1 (es) | Derivados triciclicos de 1, 4-dihidropiridina [b, e]-condensados como inhibidores de aurora quinasas | |
PE20071156A1 (es) | COMPUESTOS DERIVADOS DE 4,5,6,7-TETRAHIDRO-1H-INDAZOL COMO POTENCIADORES DEL RECEPTOR DEL ACIDO a-AMINO-3-HIDROXI-5-METILISOXAZOL-4-PROPIONICO (AMPA) | |
PE20091173A1 (es) | Derivados de heteroarilo como antagonistas de receptor de orexina | |
PE20140623A1 (es) | Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2 | |
PE20060625A1 (es) | Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina | |
PE20081612A1 (es) | Analogos de las pterinas | |
PE20080772A1 (es) | Nuevos derivados de bipiridina sustituidos y su uso | |
PE20090276A1 (es) | Compuestos derivados de imidazoquinolina como moduladores de tlr7 | |
PE20090622A1 (es) | Nuevos derivados de bencimidazol sustituido | |
PE20090241A1 (es) | Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12 | |
PE20070848A1 (es) | Derivados de pirimidina como ligandos del receptor de histamina h4 | |
PE20040687A1 (es) | Quinolinas sustituidas como antagonistas del receptor ccr5 | |
ECSP088863A (es) | Compuestos que son agonistas de receptores muscarínicos y que pueden ser eficaces en el tratamiento del dolor, la enfermedad de alzheimer y/o la esquizofrenia | |
AR079327A1 (es) | Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida | |
PE20071245A1 (es) | COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs) | |
PE20081665A1 (es) | Antagonistas del receptor de dopamina 2 de rapida disociacion | |
PE20080671A1 (es) | DERIVADOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a]PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
PE20061106A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
PE20090651A1 (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de histamina-3 | |
PE20091056A1 (es) | PIRIDO[3,2-e]PIRAZINAS, SU PROCEDIMIENTO DE PREPARACION Y USO COMO INHIBIDORES DE FOSFODIESTERASA 10 | |
PE20080371A1 (es) | N-benzoil-y-n-bencilpirrolidin-3-ilaminas como antagonistas de histamina-3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |